Pleural Diseases Global Market Report 2025

Name: Pleural Diseases Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global Pleural Diseases Market Report 2025

Pleural Diseases Global Market Report 2025 - By Disease Type (Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types ), By Treatment Modalities (Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions ), By Diagnostic Tools (Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy ), By End User (Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Pleural Diseases Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : April 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Pleural Diseases Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Pleural Diseases Market?

Pleural diseases refer to a group of conditions that affect the pleura, which is the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological pleural changes. Pleural diseases cause chest pain, shortness of breath, coughing, and difficulty breathing and are often diagnosed with imaging tests such as chest X-rays or CT scans.

The main disease types of pleural diseases are pleurisy, pleural effusion, pneumothorax, mesothelioma, and others. Pleurisy, characterized by inflammation of the pleura, causes sharp chest pain and is linked to infections or autoimmune disorders. Treatment options encompass medications, thoracentesis, pleurodesis, minimally invasive procedures, and surgical interventions. Diagnostics involve imaging techniques, molecular diagnostics, thoracoscopy, and pleuroscopy. These services are utilized in hospitals, clinics, diagnostic centers, and research or academic institutions.

Pleural Diseases Market Size and growth rate 2025 to 2029: Graph

What Is The Pleural Diseases Market Size 2025 And Growth Rate?

The pleural diseases market size has grown strongly in recent years. It will grow from $4.86 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising incidence of pleural effusion, growing awareness about pleural diseases, increasing focus on early diagnosis, growing number of healthcare facilities, and rising number of pleural disease clinical trials.

What Is The Pleural Diseases Market Growth Forecast?

The pleural diseases market size is expected to see strong growth in the next few years. It will grow to $6.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to rise in the prevalence of pleural diseases, rise in the aging population, increasing number of occupational hazards, rise in the number of clinical trials, and growing number of diagnostic centers. Major trends in the forecast period include advancements in diagnostics, advancements in diagnostic tools, adoption of minimally invasive procedures, improved drug development, and telemedicine adoption.

Book your 30 minutes free consultation with our research experts

How Is The Pleural Diseases Market Segmented?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma

5) Other Disease Types: pulmonary embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

What Is Driving The Pleural Diseases Market? Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Risk Of Infections Leading To Pleural Complications

The increasing prevalence of infectious diseases are expected to drive the growth of the pleural diseases market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites. Environmental changes to human behavior and advancements in global travel influence the increasing prevalence of infectious diseases. Infectious diseases such as bacterial pneumonia, tuberculosis, or viral infections can cause pleural disease by triggering inflammation, infection, or fluid accumulation in the pleural cavity. For instance, in January 2023, according to the National Library of Medicine, a US-based medical library for research and information, infectious diseases account for over 52 million deaths annually, placing half of the global population at risk. Further, each year, approximately 14 million children under the age of five die, with 70% of these deaths attributed to diseases that could be prevented through vaccination. Therefore, the increasing prevalence of infectious diseases drives the growth of the pleural diseases market.

Who Are The Major Players In The Global Pleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

What Are The Key Trends Of The Global Pleural Diseases Market? Advancing Treatment Accessibility With Ready-To-Use Injectable Innovations

Major companies operating in the pleural diseases market are focusing on developing innovative treatment options, such as developing ready-to-use injectable treatments, to improve convenience, reduce preparation time, and minimize dosing errors. Ready-to-use injectable treatments are pre-formulated, pre-diluted medications that require no reconstitution or mixing before administration, ensuring accuracy, convenience, and reduced preparation time. For instance, in April 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched PEMRYDI RTU, the first ready-to-use version of pemetrexed for injection. This helps people with pleural diseases by providing a convenient, ready-to-use treatment that eliminates the need for reconstitution or dilution, reduces preparation time, minimizes the risk of dosing errors, and improves access to effective therapy for conditions like malignant pleural mesothelioma.

What Are Latest Mergers And Acquisitions In The Pleural Diseases Market? Aileron Therapeutics Acquires Lung Therapeutics To Expand Pipeline For Orphan Pulmonary And Fibrosis Diseases

In October 2023, Aileron Therapeutics Inc., a US-based biopharmaceutical company, acquired Lung Therapeutics Inc. for an undisclosed amount. This acquisition strengthens the pipeline by integrating LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusions (LPEs), expanding the focus on orphan pulmonary and fibrosis diseases. Lung Therapeutics Inc. is a US-based biopharmaceutical company developing innovative peptide drugs targeting fibrosis and rare pulmonary conditions.

What Is The Regional Outlook For The Global Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pleural diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pleural Diseases Market?

The pleural diseases market consist of revenues earned by entities by providing services such as diagnostic, pleurodesis, respiratory therapy, rehabilitation, and biopsy procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The pleural diseases market also includes sales of antibiotics, chemotherapeutic agents, thoracentesis kits, chest tubes and drainage systems, and pleural biopsy needles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pleural Diseases Industry?

The pleural diseases market research report is one of a series of new reports from The Business Research Company that provides pleural diseases market statistics, including the pleural diseases industry's global market size, regional shares, competitors with a pleural diseases market share, detailed pleural diseases market segments, market trends and opportunities, and any further data you may need to thrive in the pleural diseases industry. This pleural diseases market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pleural Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$5.23 billion
Revenue Forecast In 2034	$6.94 billion
Growth Rate	CAGR of 7.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The pleural diseases market covered in this report is segmented – 1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types 2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions 3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy 4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions Subsegments: 1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy 2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax 3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma 4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma 5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pleural Diseases Market Characteristics

3. Pleural Diseases Market Trends And Strategies

4. Pleural Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pleural Diseases Growth Analysis And Strategic Analysis Framework

5.1. Global Pleural Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pleural Diseases Market Growth Rate Analysis

5.4. Global Pleural Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pleural Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pleural Diseases Total Addressable Market (TAM)

6. Pleural Diseases Market Segmentation

6.1. Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pleurisy

Pleural Effusion

Pneumothelioma

Mesothelioma

Other Disease Types

6.2. Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medications

Thoracentesis And Pleurodesis

Minimally Invasive Interventions

Surgical Interventions

6.3. Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imaging Techniques

Molecular Diagnostics

Thoracoscopy

Pleuroscopy

6.4. Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Centers

Research And Academic Institutions

6.5. Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Pleurisy

Chronic Pleurisy

Infectious Pleurisy

Non-infectious Pleurisy

6.6. Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Transudative Pleural Effusion

Exudative Pleural Effusion

Malignant Pleural Effusion

Parapneumonic Pleural Effusion

Hemothorax

Chylothorax

6.7. Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Primary Pneumothelioma

Secondary Pneumothelioma (Metastatic)

Localized Pneumothelioma

Diffuse Pneumothelioma

6.8. Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pleural Mesothelioma

Peritoneal Mesothelioma

Pericardial Mesothelioma

Testicular Mesothelioma

6.9. Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pulmonary Embolism

Fibrothorax

Pneumothorax

Lung Cancer

Tuberculosis-Related Pleural Disease

Sarcoidosis

7. Pleural Diseases Market Regional And Country Analysis

7.1. Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pleural Diseases Market

8.1. Asia-Pacific Pleural Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pleural Diseases Market

9.1. China Pleural Diseases Market Overview

9.2. China Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pleural Diseases Market

10.1. India Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pleural Diseases Market

11.1. Japan Pleural Diseases Market Overview

11.2. Japan Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pleural Diseases Market

12.1. Australia Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pleural Diseases Market

13.1. Indonesia Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pleural Diseases Market

14.1. South Korea Pleural Diseases Market Overview

14.2. South Korea Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pleural Diseases Market

15.1. Western Europe Pleural Diseases Market Overview

15.2. Western Europe Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pleural Diseases Market

16.1. UK Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pleural Diseases Market

17.1. Germany Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pleural Diseases Market

18.1. France Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pleural Diseases Market

19.1. Italy Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pleural Diseases Market

20.1. Spain Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pleural Diseases Market

21.1. Eastern Europe Pleural Diseases Market Overview

21.2. Eastern Europe Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pleural Diseases Market

22.1. Russia Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pleural Diseases Market

23.1. North America Pleural Diseases Market Overview

23.2. North America Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pleural Diseases Market

24.1. USA Pleural Diseases Market Overview

24.2. USA Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pleural Diseases Market

25.1. Canada Pleural Diseases Market Overview

25.2. Canada Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pleural Diseases Market

26.1. South America Pleural Diseases Market Overview

26.2. South America Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pleural Diseases Market

27.1. Brazil Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pleural Diseases Market

28.1. Middle East Pleural Diseases Market Overview

28.2. Middle East Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pleural Diseases Market

29.1. Africa Pleural Diseases Market Overview

29.2. Africa Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pleural Diseases Market Competitive Landscape And Company Profiles

30.1. Pleural Diseases Market Competitive Landscape

30.2. Pleural Diseases Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GSK plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Astrazeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Pleural Diseases Market Other Major And Innovative Companies

31.1. Koninklijke Philips N.V.

31.2. Becton Dickinson and Company

31.3. Boehringer Ingelheim International GmbH

31.4. Sanofi SA

31.5. Penn Medicine

31.6. Henry Ford Health

31.7. Dragerwerk AG

31.8. Emory Healthcare

31.9. Boston Medical Center

31.10. Cook Medical

31.11. WakeMed

31.12. Weill Cornell Medicine

31.13. Fox Chase Cancer Center

31.14. B. Braun SE

31.15. Bicakcilar

32. Global Pleural Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pleural Diseases Market

34. Recent Developments In The Pleural Diseases Market

35. Pleural Diseases Market High Potential Countries, Segments and Strategies

35.1 Pleural Diseases Market In 2029 - Countries Offering Most New Opportunities

35.2 Pleural Diseases Market In 2029 - Segments Offering Most New Opportunities

35.3 Pleural Diseases Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Bristol Myers Squibb Company Financial Performance

Table 83: GSK plc Financial Performance

Table 84: Astrazeneca plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Bristol Myers Squibb Company Financial Performance

Figure 83: GSK plc Financial Performance

Figure 84: Astrazeneca plc Financial Performance

How is the Allergy Diagnostics Market Poised for Growth: Trends and Opportunities Through 2034

Future Outlook of the Ambulatory Electronic Medical Records Market: Growth, Trends, and Emerging Opportunities Explored

Antimicrobial Susceptibility Testing Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Assisted Reproductive Technology Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

How is the Bed Monitoring System & Baby Monitoring System Market Poised for Growth: Trends and Opportunities Through 2034

Growth Opportunities and Trends in the Biopharmaceutical CMO Market: Key Insights for 2025-2034

How Will the Bipolar Disorder Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond

Key Trends and Insights into the Bleeding Disorders Treatment Market: Growth Rate and Opportunities to 2034

Liver Diseases Therapeutics Global Market Report 2025 – By Disease Type( Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment( Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids ), By End User( Hospitals, Ambulatory Surgery Centers, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rare Diseases Treatment Global Market Report 2025 – By Drug Type( Originator Drugs (Patented Molecules), Generic Drugs), By Drug Class( Biologics, Organic Compounds), By Mode Of Administration( Injectable, Oral, Other Modes Of Administration), By Therapeutic Area( Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Disorders, Endocrine Disorders, Other Therapeutic Areas ), By Distribution Channel( Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rare Kidney Diseases Global Market Report 2025 – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications), By Type of Molecule ( Small Molecules, Biologics), By Route of administration (Oral, Intravenous, Subcutaneous, Other Routes of Administration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiometabolic Diseases Global Market Report 2025 – By Type (Chronic/Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity), By Treatment (ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments), By Dosage (Tablet, Injection), By Route Of Administration (Oral, Intravenous, Other Routes Of Administration ), By End-Users (Clinic, Hospital, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Medical Foods For Orphan Diseases Global Market Report 2025 – By Product (Pills, Powder, Liquid, Other Products), By Route of Administration (Oral, Enteral), By Applications (Phenylketonuria, Tyrosinemia, Eosinophilic esophagitis, Food Protein-Induced Enterocolitis Syndrome (FPIES), Maple Syrup Urine Disease (MSUD), Homocystinuria, Other Applications), By Sales Channel (Online Sales, Institutional Sales, Retail Sales) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Reversible Airway Diseases Treatment Global Market Report 2025 – By Treatment (Chest X Ray, Computed Tomography (CT) Scan, Lung Therapies, Surgery Transplant, Medications), By Diseases (Asthma, Chronic Bronchitis, Emphysema, Cystic Fibrosis, Bronchiolitis, Other Diseases), By End-Users (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025 – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By End Use (Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Headache Disorders Global Market Report 2025 – By Type (Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types), By Treatment (Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy), By Diagnosis (Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Pleural Diseases market?

How will the Pleural Diseases market drivers and restraints affect the market dynamics? What forces will shape the Pleural Diseases industry going forward?

The Pleural Diseases market major growth driver - Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Risk Of Infections Leading To Pleural Complications. For further insights on the Pleural Diseases market, request a sample here

What is the forecast market size or the forecast market value of the Pleural Diseases market?

The Pleural Diseases market size has grown strongly in recent years. The pleural diseases market size has grown strongly in recent years. It will grow from $4.86 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising incidence of pleural effusion, growing awareness about pleural diseases, increasing focus on early diagnosis, growing number of healthcare facilities, and rising number of pleural disease clinical trials. The pleural diseases market size is expected to see strong growth in the next few years. It will grow to $6.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to rise in the prevalence of pleural diseases, rise in the aging population, increasing number of occupational hazards, rise in the number of clinical trials, and growing number of diagnostic centers. Major trends in the forecast period include advancements in diagnostics, advancements in diagnostic tools, adoption of minimally invasive procedures, improved drug development, and telemedicine adoption. For further insights on the Pleural Diseases market, request a sample here

How is the Pleural Diseases market segmented?

The Pleural Diseases market covered in this report is segmented –
1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types
2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions
3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy
4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions

Subsegments:
1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy
2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax
3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma
4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma
5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis For further insights on the Pleural Diseases market, request a sample here

Which region has the largest share of the Pleural Diseases market? What are the other regions covered in the report?

Who are the major players in the Pleural Diseases market?

What are the key trends in the Pleural Diseases market?

Major trends in the Pleural Diseases market include Advancing Treatment Accessibility With Ready-To-Use Injectable Innovations. For further insights on the Pleural Diseases market, request a sample here.

What are the major opportunities in the Pleural Diseases market? What are the strategies for the Pleural Diseases market?

For detailed insights on the major opportunities and strategies in the Pleural Diseases market, request a sample here.

How does the Pleural Diseases market relate to the overall economy and other similar markets?

For detailed insights on Pleural Diseases's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pleural Diseases industry?

For detailed insights on the mergers and acquisitions in the Pleural Diseases industry, request a sample here.

What are the key dynamics influencing the Pleural Diseases market growth? SWOT analysis of the Pleural Diseases market.

For detailed insights on the key dynamics influencing the Pleural Diseases market growth and SWOT analysis of the Pleural Diseases industry, request a sample here.

Pleural Diseases Global Market Report 2025

Pleural Diseases Global Market Report 2025

Market Insights

Related Reports

What Is Covered Under Pleural Diseases Market?

What Is The Pleural Diseases Market Size 2025 And Growth Rate?

What Is The Pleural Diseases Market Growth Forecast?

How Is The Pleural Diseases Market Segmented?

What Is Driving The Pleural Diseases Market? Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Risk Of Infections Leading To Pleural Complications

Who Are The Major Players In The Global Pleural Diseases Market?

What Are The Key Trends Of The Global Pleural Diseases Market? Advancing Treatment Accessibility With Ready-To-Use Injectable Innovations

What Are Latest Mergers And Acquisitions In The Pleural Diseases Market? Aileron Therapeutics Acquires Lung Therapeutics To Expand Pipeline For Orphan Pulmonary And Fibrosis Diseases

What Is The Regional Outlook For The Global Pleural Diseases Market?

What Defines the Pleural Diseases Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Pleural Diseases Industry?

Table Of Contents

List Of Tables

List Of Figures

How is the Allergy Diagnostics Market Poised for Growth: Trends and Opportunities Through 2034

Future Outlook of the Ambulatory Electronic Medical Records Market: Growth, Trends, and Emerging Opportunities Explored

Antimicrobial Susceptibility Testing Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Assisted Reproductive Technology Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

How is the Bed Monitoring System & Baby Monitoring System Market Poised for Growth: Trends and Opportunities Through 2034

Growth Opportunities and Trends in the Biopharmaceutical CMO Market: Key Insights for 2025-2034

How Will the Bipolar Disorder Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond

Key Trends and Insights into the Bleeding Disorders Treatment Market: Growth Rate and Opportunities to 2034

Frequently Asked Questions